Generation of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Nav1.2 protein encoded by the SCN2A gene

Stem Cell Res. 2023 Sep:71:103179. doi: 10.1016/j.scr.2023.103179. Epub 2023 Aug 8.

Abstract

A range of epilepsies, including the most severe group of developmental and epileptic encephalopathies (DEEs), are caused by gain-of-function variants in voltage-gated channels. Here we report the generation and characterisation of an iPSC cell line from the fibroblasts of a girl with early infantile DEE carrying heterozygous missense gain-of-function mutation (R1882Q) in Nav1.2(SCN2A) protein, using transient transfection with a single mRNA molecule. The established iPSC line displays typical human primed pluripotent stem cell characteristics: typical colony morphology and robust expression of pluripotency-associated marker genes, ability to give rise to derivatives of all three embryonic germ layers, and normal karyotype without any SNP array-detectable copy number variations. We anticipate that this iPSC line will be useful for the development of neuronal hyperactivity-caused human stem cell-based DEE models, advancing both understanding and potential therapy development for this debilitating condition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Diseases*
  • DNA Copy Number Variations
  • Female
  • Gain of Function Mutation
  • Humans
  • Induced Pluripotent Stem Cells*
  • NAV1.2 Voltage-Gated Sodium Channel / genetics
  • Voltage-Gated Sodium Channels*

Substances

  • Voltage-Gated Sodium Channels
  • SCN2A protein, human
  • NAV1.2 Voltage-Gated Sodium Channel